Literature DB >> 989035

Pulmonary manifestations of Sjögren's syndrome.

C V Strimlan, E C Rosenow, M B Divertie, E G Harrison.   

Abstract

A review of 343 patients with classic Sjogren's syndrome seen at the Mayo Clinic from 1967 through 1974 revealed pulmonary involvement in 31 patients (9 percent). Cough dyspnea, recurrent pneumonitis, and pleuritic pain were the primary complaints. Chest roentgenographic features included diffuse interstitial patterns, diffuse alveolar patterns, and pleural effusions. Laboratory studies revealed hypergammaglobulinemia in 16 of 22 patients tested, and 23 of the 31 patients had positive tests for anti-nuclear antibody, rheumatoid factor, or lupus erythematosus cells. Pulmonary function tests showed a restrictive ventilatory impairment or low diffusion capacity (or both in all 18 patients studied. Pathologic diagnosis included the full range of pulmonary lesions described in Sjogren's syndrome syndrome, ie, lymphocytic interstitial pneumonitis, pseudolymphoma, malignant lymphoma, diffuse interstitial pulmonary fibrosis, and bronchopneumonia. The clinical pulmonary diagnosis included diffuse interstitial fibrosis, recurrent pneumonitis, pleural effusions, and suspected lymphoma or pseudolymphoma. We conclude that pulmonary lesions occur in Sjogren's syndrome more frequently than previously reported.

Entities:  

Mesh:

Year:  1976        PMID: 989035     DOI: 10.1378/chest.70.3.354

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  42 in total

Review 1.  Non-neoplastic pulmonary lymphoid lesions.

Authors:  W D Travis; J R Galvin
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

3.  Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.

Authors:  M Yamazaki; R Kitamura; S Kusano; H Eda; S Sato; M Okawa-Takatsuji; S Aotsuka; K Yanagi
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

4.  Organizing pneumonia associated with Sjogren's syndrome: a comment.

Authors:  Sheng-Yuan Ruan; Yao-Wen Kuo
Journal:  Rheumatol Int       Date:  2008-11-07       Impact factor: 2.631

5.  Hodgkin's disease occurring in primary Sjögren's syndrome.

Authors:  J M Martín-Santos; L Carretero; A Armentia; E Alonso; I Gil
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

6.  Neutrophil function in patients with primary Sjögren's syndrome: relation to infection propensity.

Authors:  B Gudbjörnsson; N Feltelius; R Hällgren; P Venge
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

7.  Clinical significance of chronic hepatitis B virus infection in patients with primary Sjögren's syndrome.

Authors:  Ming-Han Chen; Liang-Tsai Hsiao; Ming-Huang Chen; Chang-Youh Tsai; Yi-Hsiang Huang; Chung-Tei Chou
Journal:  Clin Rheumatol       Date:  2011-08-02       Impact factor: 2.980

8.  Respiration and connective tissue diseases.

Authors:  M J Walport
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

9.  A follow-up study of pulmonary function in patients with primary Sjögren's syndrome.

Authors:  M Linstow; N J Kriegbaum; V Backer; C Ulrik; P Oxholm
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

10.  Lung function abnormalities in different connective tissue diseases.

Authors:  C Vitali; G Viegi; S Tassoni; A Tavoni; P Paoletti; E Bibolotti; C Ferri; S Bombardieri
Journal:  Clin Rheumatol       Date:  1986-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.